IMU imugene limited

18.2%

1.3¢

I hope PH puts his own money where his mouth is. That will...

First 109 Last

Share
Profile

Follow
Single

242 Posts.

74

02/05/25

11:20

Post #: 78893046
Share

Originally posted by Donvan: ↑

Approaching peak pessimism here, can't say I don't understand or feel for many actual investors/holders who are seeing 70-90% drawdowns/mark to market loss.

Nevertheless as stated Vaxinia has cured at least one individual with ~47% of advanced/failed prior treatment line treated population showing stable disease in a cohort of dose escalated trial, IV and IT OBD still to be determined. Azer Cell has also demonstrated very significant efficacy at this stage in the primary indication targeted which alone offers a multi billion annual revenue market IIRC.

There's significant value here that's not being represented by the current market capitalisation IMO while I also likely at this point see at least 50% further dilution in the relative near term - until significant more progress in OnCARlytics trialing is announced to market - unless there's significant news/data from partnerships/MAST/Vaxinia (biliary expansion or otherwise) to rerate the share price by multiple/s. I'm apprehensive that institutions/sophisticated high net worth investors won't be willing to support a capital raise of significant value at this stage and depressed valuation and therefore impeding the important work being done here to provide life saving treatments and alternatives in unaddressed indications.

No doubt many burnt investors, and also many of those waiting on the wings for more surety around finances to support operations and further positive clinical data. This end of the market especially provides outsized reward for those that are willing to take on the high degree of risk in a biotech stock especially in this/similar position.

I continue to see significant value here - but recognise the inherent risk and reasons for poor investor sentiment. I hope for not only current/future investors that the company succeeds but that these potential cutting edge, highly efficacious treatments are able to save numerous lives that otherwise would be without hope.

GLTAH & IMO

Expand

I hope PH puts his own money where his mouth is. That will ignite confidence again for the investors on the street.
We are out of cash beyond the next two quarters and raising money now at 2c would be nothing short of a disaster for us retailers.

IMU Price at posting: 2.3¢ Sentiment: Sell Disclosure: Held
4 Upvote

0 Great analysis

Reply

Top Stories

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 109 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.3¢		Change 0.002(18.2%)		Mkt cap ! $97.07M

Open	High	Low	Value	Volume
1.2¢	1.4¢	1.1¢	$625.7K	50.56M

Buyers (Bids)

No.	Vol.	Price($)
20	5795292	1.2¢

Sellers (Offers)

Price($)	Vol.	No.
1.3¢	3258567	9

View Market Depth

No.	Vol.	Price($)
18	5735292	0.012
35	10497532	0.011
118	35980571	0.010
37	19431668	0.009
13	4220748	0.008

Price($)	Vol.	No.
0.013	3078567	8
0.014	10063029	39
0.015	6593187	20
0.016	6224494	27
0.017	7006978	10

Last trade - 16.10pm 27/06/2025 (20 minute delay)

IMU (ASX) Chart

I hope PH puts his own money where his mouth is. That will...

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Monash IVF shares cater 25% – Disaster or deep-value play?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

I hope PH puts his own money where his mouth is. That will...

Top Stories

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Monash IVF shares cater 25% – Disaster or deep-value play?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

Australia’s gas crisis is here – and dying coal plants aren’t helping

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News